Expert Opinion on Drug Metabolism and Toxicology

SJR Rank #5,000H-index: 112SJR: 0.986Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q1
  • ToxicologyQ1
  • PharmacologyQ2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsComputational Drug Discovery MethodsPharmacological Effects and Toxicity StudiesDrug-Induced Hepatotoxicity and ProtectionHIV/AIDS drug development and treatmentAntibiotics Pharmacokinetics and EfficacyDiabetes Treatment and ManagementPharmaceutical studies and practicesEicosanoids and Hypertension Pharmacology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs060120180240

Documents per Year

202220250306090120

Detailed Information

ISSN

1742-5255, 1744-7607

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.52

References per Document

84.62

Coverage

2005-2026

Scope

Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.

Metrics from SCImago Journal Rank 2025. View on SCImago